{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:57:19Z","timestamp":1794610639481,"version":"4.9.1"},"reference-count":259,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hematological malignancies are a highly heterogeneous group of diseases with varied molecular and phenotypical characteristics. SWI\/SNF (SWItch\/Sucrose Non-Fermentable) chromatin remodeling complexes play significant roles in the regulation of gene expression, being essential for processes such as cell maintenance and differentiation in hematopoietic stem cells. Furthermore, alterations in SWI\/SNF complex subunits, especially in ARID1A\/1B\/2, SMARCA2\/4, and BCL7A, are highly recurrent across a wide variety of lymphoid and myeloid malignancies. Most genetic alterations cause a loss of function of the subunit, suggesting a tumor suppressor role. However, SWI\/SNF subunits can also be required for tumor maintenance or even play an oncogenic role in certain disease contexts. The recurrent alterations of SWI\/SNF subunits highlight not only the biological relevance of SWI\/SNF complexes in hematological malignancies but also their clinical potential. In particular, increasing evidence has shown that mutations in SWI\/SNF complex subunits confer resistance to several antineoplastic agents routinely used for the treatment of hematological malignancies. Furthermore, mutations in SWI\/SNF subunits often create synthetic lethality relationships with other SWI\/SNF or non-SWI\/SNF proteins that could be exploited therapeutically. In conclusion, SWI\/SNF complexes are recurrently altered in hematological malignancies and some SWI\/SNF subunits may be essential for tumor maintenance. These alterations, as well as their synthetic lethal relationships with SWI\/SNF and non-SWI\/SNF proteins, may be pharmacologically exploited for the treatment of diverse hematological cancers.<\/jats:p>","DOI":"10.1186\/s12943-023-01736-8","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T03:44:43Z","timestamp":1676951083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["SWI\/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities"],"prefix":"10.1186","volume":"22","author":[{"given":"Alvaro","family":"Andrades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Alvarez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sanjuan-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Matia-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro P.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"1736_CR1","unstructured":"International Agency for Research on Cancer. Cancer Today. Available from: https:\/\/gco.iarc.fr\/today. [cited 10 Jan 2023]."},{"key":"1736_CR2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ije\/dyy044","volume":"47","author":"A Smith","year":"2018","unstructured":"Smith A, Howell D, Crouch S, Painter D, Blase J, Wang HI, et al. Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort. Int J Epidemiol. 2018;47:700\u2013700g Oxford Academic. Available from: https:\/\/academic.oup.com\/ije\/article\/47\/3\/700\/4958802 [cited 8 Jul 2022].","journal-title":"Int J Epidemiol"},{"key":"1736_CR3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Lee Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/127\/20\/2375\/35286\/The-2016-revision-of-the-World-Health-Organization [cited 8 Jul 2022].","journal-title":"Blood"},{"issue":"7","key":"1736_CR4","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-022-01620-2[cited 11 Jul 2022].","journal-title":"Leukemia"},{"issue":"7","key":"1736_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-022-01613-1 [cited 11 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR6","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1182\/blood.2020005335","volume":"135","author":"RD Morin","year":"2020","unstructured":"Morin RD, Scott DW. DLBCL subclassification: divide and conquer? Blood. 2020;135:1722\u20134 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/135\/20\/1722\/454958\/DLBCL-subclassification-divide-and-conquer [cited 11 Nov 2022].","journal-title":"Blood"},{"key":"1736_CR7","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med. 2018;378:1396\u2013407 New England Journal of Medicine (NEJM\/MMS). Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1801445 [cited 8 Jul 2022].","journal-title":"N Engl J Med"},{"issue":"5","key":"1736_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679\u201390 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41591-018-0016-8 [cited 8 Jul 2022].","journal-title":"Nat Med"},{"key":"1736_CR9","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy SE, Barrans SL, Beer PA, Painter D, Smith AG, Roman E, et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 2020;135:1759\u201371 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/135\/20\/1759\/452715\/Targeted-sequencing-in-DLBCL-molecular-subtypes [cited 25 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/gad.284109.116","volume":"30","author":"D Hu","year":"2016","unstructured":"Hu D, Shilatifard A. Epigenetics of hematopoiesis and hematological malignancies. Genes Dev. 2016;30:2021\u201341 Cold Spring Harbor Laboratory Press.","journal-title":"Genes Dev"},{"key":"1736_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/cas.13168","volume":"108","author":"S Goyama","year":"2017","unstructured":"Goyama S, Kitamura T. Epigenetics in normal and malignant hematopoiesis: an overview and update 2017. Cancer Sci. 2017;108:553\u201362 Blackwell Publishing Ltd.","journal-title":"Cancer Sci"},{"key":"1736_CR12","unstructured":"Huether R, Dong L, Chen X, Wu G, Parker M, Wei L, et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun. 2014;5:3630. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/ncomms4630. [cited 17 Jul 2022]."},{"issue":"2","key":"1736_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.2651","volume":"18","author":"P Ntziachristos","year":"2012","unstructured":"Ntziachristos P, Tsirigos A, van Vlierberghe P, Nedjic J, Trimarchi T, Flaherty MS, et al. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med. 2012;18(2):298\u2013302 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/nm.2651 [cited 17 Jul 2022].","journal-title":"Nat Med"},{"key":"1736_CR14","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"The Cancer Genome Atlas Research Network","year":"2013","unstructured":"The Cancer Genome Atlas Research Network. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med."},{"key":"1736_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42:181\u20135.","journal-title":"Nat Genet"},{"key":"1736_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476:298\u2013303.","journal-title":"Nature."},{"key":"1736_CR17","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","volume":"121","author":"M Neumann","year":"2013","unstructured":"Neumann M, Heesch S, Schlee C, Schwartz S, G\u00f6kbuget N, Hoelzer D, et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood. 2013;121:4749\u201352 American Society of Hematology.","journal-title":"Blood"},{"key":"1736_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011;471:189\u201396.","journal-title":"Nature."},{"key":"1736_CR19","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1182\/blood-2013-01-451781","volume":"121","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab O, Levine RL. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood. 2013;121:3563\u201372 American Society of Hematology.","journal-title":"Blood"},{"key":"1736_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ng.621","volume":"42","author":"T Ernst","year":"2010","unstructured":"Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones A, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet. 2010;42:722\u20136.","journal-title":"Nat Genet"},{"key":"1736_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ng.620","volume":"42","author":"G Nikoloski","year":"2010","unstructured":"Nikoloski G, Langemeijer SMC, Kuiper RP, Knops R, Massop M, T\u00f6nnissen ERLTM, et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet. 2010;42:665\u20137.","journal-title":"Nat Genet"},{"key":"1736_CR22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44:1321\u20135.","journal-title":"Nat Genet."},{"key":"1736_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semcancer.2017.07.005","volume":"51","author":"P Gallipoli","year":"2018","unstructured":"Gallipoli P, Huntly BJP. Novel epigenetic therapies in hematological malignancies: current status and beyond. Semin Cancer Biol. 2018;51:198\u2013210 Academic Press.","journal-title":"Semin Cancer Biol"},{"key":"1736_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-4939-8751-1_5","volume":"1856","author":"N Cruz-Rodriguez","year":"2018","unstructured":"Cruz-Rodriguez N, Combita AL, Zabaleta J. Epigenetics in Hematological Malignancies. Methods Mol Biol. 2018;1856:87\u2013101 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30178247\/ [cited 17 Jul 2022].","journal-title":"Methods Mol Biol"},{"key":"1736_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/apm.12906","volume":"127","author":"K Dimopoulos","year":"2019","unstructured":"Dimopoulos K, Gr\u00f8nb\u00e6k K. Epigenetic therapy in hematological cancers. APMIS. 2019;127:316\u201328 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30859683\/ [cited 17 Jul 2022].","journal-title":"APMIS"},{"issue":"3","key":"1736_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","volume":"19","author":"PA Jones","year":"2019","unstructured":"Jones PA, Ohtani H, Chakravarthy A, de Carvalho DD. Epigenetic therapy in immune-oncology. Nat Rev Cancer. 2019;19(3):151\u201361 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41568-019-0109-9 [cited 17 Jul 2022].","journal-title":"Nat Rev Cancer"},{"key":"1736_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","volume":"78","author":"CR Clapier","year":"2009","unstructured":"Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273\u2013304 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19355820\/ [cited 24 Jul 2022].","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"1736_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","volume":"11","author":"BG Wilson","year":"2011","unstructured":"Wilson BG, Roberts CWM. SWI\/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11(7):481\u201392 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/nrc3068 [cited 19 Jul 2022].","journal-title":"Nat Rev Cancer"},{"key":"1736_CR29","doi-asserted-by":"publisher","first-page":"a026930","DOI":"10.1101\/cshperspect.a026930","volume":"6","author":"C Hodges","year":"2016","unstructured":"Hodges C, Kirkland JG, Crabtree GR. The Many Roles of BAF (mSWI\/SNF) and PBAF Complexes in Cancer. Cold Spring Harb Perspect Med. 2016;6:a026930 Cold Spring Harbor Laboratory Press. Available from: http:\/\/perspectivesinmedicine.cshlp.org\/content\/6\/8\/a026930.full [cited 24 Jul 2022].","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1736_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.critrevonc.2018.01.009","volume":"123","author":"S Savas","year":"2018","unstructured":"Savas S, Skardasi G. The SWI\/SNF complex subunit genes: their functions, variations, and links to risk and survival outcomes in human cancers. Crit Rev Oncol Hematol. 2018;123:114\u201331 Elsevier.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1736_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.dnarep.2019.03.007","volume":"77","author":"C Ribeiro-Silva","year":"2019","unstructured":"Ribeiro-Silva C, Vermeulen W, Lans H. SWI\/SNF: complex complexes in genome stability and cancer. DNA Repair (Amst). 2019;77:87\u201395 Elsevier.","journal-title":"DNA Repair (Amst)"},{"key":"1736_CR32","doi-asserted-by":"publisher","first-page":"e1500447","DOI":"10.1126\/sciadv.1500447","volume":"1","author":"C Kadoch","year":"2015","unstructured":"Kadoch C, Crabtree GR. Mammalian SWI\/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics. Sci Adv. 2015;1:e1500447 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26601204\/ [cited 17 Jan 2023].","journal-title":"Sci Adv"},{"key":"1736_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MOH.0000000000000710","volume":"29","author":"Z Tu","year":"2022","unstructured":"Tu Z, Zheng Y. Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance. Curr Opin Hematol. 2022;29:174\u201380 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35787545\/ [cited 14 Sep 2022].","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"1736_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-020-00422-1","volume":"6","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wang P, Li Y, Peng H, Zhu Y, Mohandas N, et al. Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies. Signal Transduct Target Ther. 2021;6(1):24.","journal-title":"Signal Transduct Target Ther."},{"key":"1736_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.exphem.2020.12.004","volume":"94","author":"T Bluemn","year":"2021","unstructured":"Bluemn T, Schmitz J, Chen Y, Zheng Y, Zhang Y, Zheng S, et al. Arid2 regulates hematopoietic stem cell differentiation in normal hematopoiesis. Exp Hematol. 2021;94:37\u201346 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33346030\/ [cited 4 Aug 2022].","journal-title":"Exp Hematol"},{"key":"1736_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41375-021-01505-w","volume":"36","author":"T Bluemn","year":"2022","unstructured":"Bluemn T, Schmitz J, Zheng Y, Burns R, Zheng S, DeJong J, et al. Differential roles of BAF and PBAF subunits, Arid1b and Arid2, in MLL-AF9 leukemogenesis. Leukemia. 2022;36:946\u201355 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35022500\/ [cited 4 Aug 2022].","journal-title":"Leukemia"},{"key":"1736_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-018-0567-7","volume":"11","author":"L Liu","year":"2018","unstructured":"Liu L, Wan X, Zhou P, Zhou X, Zhang W, Hui X, et al. The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis. J Hematol Oncol. 2018;11:27 BioMed Central Ltd.","journal-title":"J Hematol Oncol"},{"key":"1736_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1101\/sqb.2016.81.031021","volume":"81","author":"JL Pulice","year":"2016","unstructured":"Pulice JL, Kadoch C. Composition and Function of Mammalian SWI\/SNF Chromatin Remodeling Complexes in Human Disease. Cold Spring Harb Symp Quant Biol. 2016;81:53\u201360 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28408647\/ [cited 19 Jul 2022].","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1736_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2009.01.009","volume":"136","author":"JI Wu","year":"2009","unstructured":"Wu JI, Lessard J, Crabtree GR. Understanding the words of chromatin regulation. Cell. 2009;136:200\u20136 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19167321\/ [cited 19 Jul 2022].","journal-title":"Cell"},{"key":"1736_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","volume":"175","author":"N Mashtalir","year":"2018","unstructured":"Mashtalir N, D\u2019Avino AR, Michel BC, Luo J, Pan J, Otto JE, et al. Modular Organization and Assembly of SWI\/SNF Family Chromatin Remodeling Complexes. Cell. 2018;175:1272\u20131288.e20 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30343899\/ [cited 13 Sep 2022].","journal-title":"Cell"},{"key":"1736_CR41","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1074\/jbc.RA117.001065","volume":"293","author":"A Alpsoy","year":"2018","unstructured":"Alpsoy A, Dykhuizen EC. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI\/SNF chromatin remodeling subcomplexes. J Biol Chem. 2018;293:3892\u2013903.","journal-title":"J Biol Chem."},{"key":"1736_CR42","doi-asserted-by":"publisher","first-page":"e22631","DOI":"10.7554\/eLife.22631","volume":"6","author":"HW King","year":"2017","unstructured":"King HW, Klose RJ. The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells. Elife. 2017;6:e22631 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28287392\/ [cited 13 Sep 2022].","journal-title":"Elife"},{"key":"1736_CR43","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1111\/febs.14660","volume":"285","author":"S Sammak","year":"2018","unstructured":"Sammak S, Allen MD, Hamdani N, Bycroft M, Zinzalla G. The structure of INI1\/hSNF5 RPT1 and its interactions with the c-MYC: MAX heterodimer provide insights into the interplay between MYC and the SWI\/SNF chromatin remodeling complex. FEBS J. 2018;285:4165\u201380 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30222246\/ [cited 13 Sep 2022].","journal-title":"FEBS J"},{"key":"1736_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-019-1115-5","volume":"569","author":"D Barisic","year":"2019","unstructured":"Barisic D, Stadler MB, Iurlaro M, Sch\u00fcbeler D. Mammalian ISWI and SWI\/SNF selectively mediate binding of distinct transcription factors. Nature. 2019;569:136\u201340.","journal-title":"Nature."},{"key":"1736_CR45","doi-asserted-by":"publisher","first-page":"110637","DOI":"10.1016\/j.celrep.2022.110637","volume":"39","author":"S Carcamo","year":"2022","unstructured":"Carcamo S, Nguyen CB, Grossi E, Filipescu D, Alpsoy A, Dhiman A, et al. Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma. Cell Rep. 2022;39:110637 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35385731\/ [cited 13 Sep 2022].","journal-title":"Cell Rep"},{"key":"1736_CR46","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1080\/15384101.2020.1831256","volume":"19","author":"E Hays","year":"2020","unstructured":"Hays E, Nettleton E, Carter C, Morales M, Vo L, Passo M, et al. The SWI\/SNF ATPase BRG1 stimulates DNA end resection and homologous recombination by reducing nucleosome density at DNA double strand breaks and by promoting the recruitment of the CtIP nuclease. Cell Cycle. 2020;19:3096\u2013114 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33044911\/ [cited 13 Sep 2022].","journal-title":"Cell Cycle"},{"key":"1736_CR47","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41588-021-00867-2","volume":"53","author":"A Bayona-Feliu","year":"2021","unstructured":"Bayona-Feliu A, Barroso S, Mu\u00f1oz S, Aguilera A. The SWI\/SNF chromatin remodeling complex helps resolve R-loop-mediated transcription-replication conflicts. Nat Genet. 2021;53:1050\u201363 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33986538\/ [cited 13 Sep 2022].","journal-title":"Nat Genet"},{"key":"1736_CR48","doi-asserted-by":"publisher","first-page":"eabe7804","DOI":"10.1126\/sciadv.abe7804","volume":"7","author":"CSY Lo","year":"2021","unstructured":"Lo CSY, van Toorn M, Gaggioli V, Dias MP, Zhu Y, Manolika EM, et al. SMARCAD1-mediated active replication fork stability maintains genome integrity. Sci Adv. 2021;7:eabe7804 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33952518\/ [cited 13 Sep 2022].","journal-title":"Sci Adv"},{"key":"1736_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0092-8674(00)81785-7","volume":"95","author":"JA Armstrong","year":"1998","unstructured":"Armstrong JA, Bieker JJ, Emerson BM. A SWI\/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell. 1998;95:93\u2013104 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9778250\/ [cited 14 Sep 2022].","journal-title":"Cell"},{"key":"1736_CR50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jcp.22240","volume":"225","author":"R Bakshi","year":"2010","unstructured":"Bakshi R, Hassan MQ, Pratap J, Lian JB, Montecino MA, van Wijnen AJ, et al. The human SWI\/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J Cell Physiol. 2010;225:569\u201376 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20506188\/ [cited 14 Sep 2022].","journal-title":"J Cell Physiol"},{"key":"1736_CR51","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1101\/gad.232710.113","volume":"27","author":"J Shi","year":"2013","unstructured":"Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS, et al. Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 2013;27:2648\u201362 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24285714\/ [cited 14 Sep 2022].","journal-title":"Genes Dev"},{"key":"1736_CR52","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1073\/pnas.0506164102","volume":"102","author":"H Im","year":"2005","unstructured":"Im H, Grass JA, Johnson KD, Kim SI, Boyer ME, Imbalzano AN, et al. Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc Natl Acad Sci U S A. 2005;102:17065\u201370.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1736_CR53","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1128\/MCB.20.20.7572-7582.2000","volume":"20","author":"DW O\u2019Neill","year":"2000","unstructured":"O\u2019Neill DW, Schoetz SS, Lopez RA, Castle M, Rabinowitz L, Shor E, et al. An Ikaros-containing chromatin-remodeling complex in adult-type Erythroid cells. Mol Cell Biol. 2000;20:7572\u201382.","journal-title":"Mol Cell Biol."},{"key":"1736_CR54","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1182\/blood-2012-04-427047","volume":"120","author":"V Krasteva","year":"2012","unstructured":"Krasteva V, Buscarlet M, Diaz-Tellez A, Bernard MA, Crabtree GR, Lessard JA. The BAF53a subunit of SWI\/SNF-like BAF complexes is essential for hemopoietic stem cell function. Blood. 2012;120:4720\u201332 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23018638\/ [cited 14 Sep 2022].","journal-title":"Blood"},{"issue":"9","key":"1736_CR55","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1038\/s41375-019-0438-4","volume":"33","author":"L Han","year":"2019","unstructured":"Han L, Madan V, Mayakonda A, Dakle P, Woon TW, Shyamsunder P, et al. Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice. Leukemia. 2019;33(9):2291\u2013305 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-019-0438-4 [cited 14 Sep 2022].","journal-title":"Leukemia"},{"key":"1736_CR56","doi-asserted-by":"publisher","first-page":"19134","DOI":"10.18632\/oncotarget.8102","volume":"7","author":"H Lee","year":"2016","unstructured":"Lee H, Dai F, Zhuang L, Xiao ZD, Kim J, Zhang Y, et al. BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21. Oncotarget. 2016;7:19134\u201346 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26992241\/ [cited 14 Sep 2022].","journal-title":"Oncotarget"},{"key":"1736_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.exphem.2016.11.008","volume":"48","author":"V Krasteva","year":"2017","unstructured":"Krasteva V, Crabtree GR, Lessard JA. The BAF45a\/PHF10 subunit of SWI\/SNF-like chromatin remodeling complexes is essential for hematopoietic stem cell maintenance. Exp Hematol. 2017;48:58\u201371.e15 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27931852\/ [cited 14 Sep 2022].","journal-title":"Exp Hematol"},{"key":"1736_CR58","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41375-021-01426-8","volume":"36","author":"SR Naidu","year":"2022","unstructured":"Naidu SR, Capitano M, Ropa J, Cooper S, Huang X, Broxmeyer HE. Chromatin remodeling subunit BRM and valine regulate hematopoietic stem\/progenitor cell function and self-renewal via intrinsic and extrinsic effects. Leukemia. 2022;36:821\u201333 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34599272\/ [cited 15 Sep 2022].","journal-title":"Leukemia"},{"key":"1736_CR59","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.1900959","volume":"205","author":"A Astori","year":"2020","unstructured":"Astori A, Tingvall-Gustafsson J, Kuruvilla J, Coyaud E, Laurent EMN, Sunnerhagen M, et al. ARID1a Associates with Lymphoid-Restricted Transcription Factors and Has an Essential Role in T Cell Development. J Immunol. 2020;205:1419\u201332 The American Association of Immunologists. Available from: https:\/\/www.jimmunol.org\/content\/205\/5\/1419 [cited 14 Sep 2022].","journal-title":"J Immunol"},{"key":"1736_CR60","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1101\/gad.1364105","volume":"19","author":"SJ Bultman","year":"2005","unstructured":"Bultman SJ, Gebuhr TC, Magnuson T. A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI\/SNF-related complexes in \u03b2-globin expression and erythroid development. Genes Dev. 2005;19:2849\u201361 Cold Spring Harbor Laboratory Press. Available from: http:\/\/genesdev.cshlp.org\/content\/19\/23\/2849.full [cited 14 Sep 2022].","journal-title":"Genes Dev"},{"key":"1736_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1242\/dev.010090","volume":"135","author":"CT Griffin","year":"2008","unstructured":"Griffin CT, Brennan J, Magnuson T. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development. 2008;135:493\u2013500.","journal-title":"Development."},{"key":"1736_CR62","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1101\/gr.121145.111","volume":"21","author":"G Hu","year":"2011","unstructured":"Hu G, Schones DE, Cui K, Ybarra R, Northrup D, Tang Q, et al. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res. 2011;21:1650\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21795385\/ [cited 15 Sep 2022].","journal-title":"Genome Res"},{"key":"1736_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jcp.20432","volume":"206","author":"D Vradii","year":"2006","unstructured":"Vradii D, Wagner S, Doan DN, Nickerson JA, Montecino M, Lian JB, et al. Brg1, the ATPase subunit of the SWI\/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes. J Cell Physiol. 2006;206:112\u20138 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcp.20432 [cited 14 Sep 2022].","journal-title":"J Cell Physiol"},{"issue":"6894","key":"1736_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature00876","volume":"418","author":"TH Chi","year":"2002","unstructured":"Chi TH, Wan M, Zhao K, Taniuchi I, Chen L, Uttman DR, et al. Reciprocal regulation of CD4\/CD8 expression by SWI\/SNF-like BAF complexes. Nature. 2002;418(6894):195\u20139 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/nature00876 [cited 14 Sep 2022].","journal-title":"Nature"},{"key":"1736_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1074-7613(03)00199-7","volume":"19","author":"TH Chi","year":"2003","unstructured":"Chi TH, Wan M, Lee PP, Akashi K, Metzger D, Chambon P, et al. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity. 2003;19:169\u201382 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12932351\/ [cited 14 Sep 2022].","journal-title":"Immunity"},{"key":"1736_CR66","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20030714","volume":"198","author":"TC Gebuhr","year":"2003","unstructured":"Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003;198:1937\u201349 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/14676303\/ [cited 14 Sep 2022].","journal-title":"J Exp Med"},{"key":"1736_CR67","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.4049\/jimmunol.1103390","volume":"188","author":"J Choi","year":"2012","unstructured":"Choi J, Ko M, Jeon S, Jeon Y, Park K, Lee C, et al. The SWI\/SNF-like BAF Complex Is Essential for Early B Cell Development. J Immunol. 2012;188:3791\u2013803 American Association of Immunologists. Available from: https:\/\/www.jimmunol.org\/content\/188\/8\/3791 [cited 14 Sep 2022].","journal-title":"J Immunol"},{"key":"1736_CR68","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s12276-022-00769-1","volume":"54","author":"P Azad","year":"2022","unstructured":"Azad P, Caldwell AB, Ramachandran S, Spann NJ, Akbari A, Villafuerte FC, et al. ARID1B, a molecular suppressor of erythropoiesis, is essential for the prevention of Monge\u2019s disease. Exp Mol Med. 2022;54:777\u201387 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35672450\/ [cited 14 Sep 2022].","journal-title":"Exp Mol Med"},{"issue":"5","key":"1736_CR69","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ng.3812","volume":"49","author":"P Priam","year":"2017","unstructured":"Priam P, Krasteva V, Rousseau P, D\u2019Angelo G, Gaboury L, Sauvageau G, et al. SMARCD2 subunit of SWI\/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBP\u025b dependent mechanism. Nat Genet. 2017;49(5):753\u201364 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3812 [cited 15 Sep 2022].","journal-title":"Nat Genet"},{"key":"1736_CR70","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/ng.3833","volume":"49","author":"M Witzel","year":"2017","unstructured":"Witzel M, Petersheim D, Fan Y, Bahrami E, Racek T, Rohlfs M, et al. Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet. 2017;49:742\u201352 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28369036\/ [cited 15 Jan 2023].","journal-title":"Nat Genet"},{"key":"1736_CR71","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ni925","volume":"4","author":"P Liu","year":"2003","unstructured":"Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, et al. Bcl11a is essential for normal lymphoid development. Nat Immunol. 2003;4:525\u201332 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12717432\/ [cited 14 Sep 2022].","journal-title":"Nat Immunol"},{"key":"1736_CR72","doi-asserted-by":"crossref","unstructured":"Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, van Handel B, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322:1839\u201342. American Association for the Advancement of Science.\u00a0Available from: https:\/\/www.science.org\/doi\/10.1126\/science.1165409. [cited 14 Sep 2022].","DOI":"10.1126\/science.1165409"},{"key":"1736_CR73","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/nature08243","volume":"460","author":"VG Sankaran","year":"2009","unstructured":"Sankaran VG, Xu J, Ragoczy T, Ippolito GC, Walkley CR, Maika SD, et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature. 2009;460:1093\u20137 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19657335\/ [cited 14 Sep 2022].","journal-title":"Nature"},{"key":"1736_CR74","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1101\/gad.1897310","volume":"24","author":"J Xu","year":"2010","unstructured":"Xu J, Sankaran VG, Ni M, Menne TF, Puram RV, Kim W, et al. Transcriptional silencing of gamma-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 2010;24:783\u201398.","journal-title":"Genes Dev."},{"key":"1736_CR75","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","volume":"173","author":"N Liu","year":"2018","unstructured":"Liu N, Hargreaves VV, Zhu Q, Kurland JV, Hong J, Kim W, et al. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch. Cell. 2018;173:430\u2013442.e17 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29606353\/ [cited 14 Sep 2022].","journal-title":"Cell"},{"key":"1736_CR76","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1016\/j.celrep.2016.08.064","volume":"16","author":"S Luc","year":"2016","unstructured":"Luc S, Huang J, McEldoon JL, Somuncular E, Li D, Rhodes C, et al. Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype. Cell Rep. 2016;16:3181\u201394 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27653684\/ [cited 15 Jan 2023].","journal-title":"Cell Rep"},{"key":"1736_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ni927","volume":"4","author":"Y Wakabayashi","year":"2003","unstructured":"Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, et al. Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol. 2003;4:533\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12717433\/ [cited 14 Sep 2022].","journal-title":"Nat Immunol"},{"key":"1736_CR78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.immuni.2020.06.011","volume":"53","author":"CS Loo","year":"2020","unstructured":"Loo CS, Gatchalian J, Liang Y, Leblanc M, Xie M, Ho J, et al. A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function. Immunity. 2020;53:143\u2013157.e8 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32640256\/ [cited 14 Sep 2022].","journal-title":"Immunity"},{"key":"1736_CR79","doi-asserted-by":"publisher","first-page":"11997","DOI":"10.1096\/fj.201903168RR","volume":"34","author":"J Tu","year":"2020","unstructured":"Tu J, Liu X, Jia H, Reilly J, Yu S, Cai C, et al. The chromatin remodeler Brg1 is required for formation and maintenance of hematopoietic stem cells. FASEB J. 2020;34:11997\u20132008 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32738093\/ [cited 15 Sep 2022].","journal-title":"FASEB J"},{"key":"1736_CR80","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1182\/blood-2016-02-702464","volume":"128","author":"J Choi","year":"2016","unstructured":"Choi J, Kim YK, Park K, Nah J, Yoon SS, Kim DW, et al. MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis. Blood. 2016;128:2117\u201329 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27605510\/ [cited 15 Sep 2022].","journal-title":"Blood"},{"key":"1736_CR81","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.4049\/jimmunol.178.11.7088","volume":"178","author":"KY Lee","year":"2007","unstructured":"Lee KY, Choi YI, Kim J, Choi JW, Sohn DH, Lee C, et al. Down-Regulation of the SWI\/SNF Chromatin Remodeling Activity by TCR Signaling Is Required for Proper Thymocyte Maturation. J Immunol. 2007;178:7088\u201396 American Association of Immunologists. Available from: https:\/\/www.jimmunol.org\/content\/178\/11\/7088 [cited 14 Sep 2022].","journal-title":"J Immunol"},{"key":"1736_CR82","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017;171:481\u2013494.e15 Cell Press.","journal-title":"Cell"},{"issue":"1","key":"1736_CR83","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1038\/s41467-018-06354-3","volume":"9","author":"SE Arthur","year":"2018","unstructured":"Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, et al. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018;9(1):4001.","journal-title":"Nat Commun."},{"issue":"8","key":"1736_CR84","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/leu.2016.69","volume":"30","author":"V Madan","year":"2016","unstructured":"Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. 2016;30(8):1672\u201381 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/leu201669 [cited 16 Sep 2022].","journal-title":"Leukemia"},{"key":"1736_CR85","doi-asserted-by":"publisher","first-page":"e0142806","DOI":"10.1371\/journal.pone.0142806","volume":"10","author":"AV Cruickshank","year":"2015","unstructured":"Cruickshank AV, Sroczynska P, Sankar A, Miyagi S, Rundsten CF, Johansen JV, et al. SWI\/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance. PLoS One. 2015;10:e0142806 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26571505\/ [cited 3 Oct 2022].","journal-title":"PLoS One"},{"key":"1736_CR86","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41375-020-0919-5","volume":"34","author":"C Bali\u00f1as-Gavira","year":"2020","unstructured":"Bali\u00f1as-Gavira C, Rodr\u00edguez MI, Andrades A, Cuadros M, \u00c1lvarez-P\u00e9rez JC, \u00c1lvarez-Prado \u00c1F, et al. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL. Leukemia. 2020;34:2722\u201335 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32576963\/ [cited 16 Sep 2022].","journal-title":"Leukemia"},{"key":"1736_CR87","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2013-02-483495","volume":"123","author":"M Buscarlet","year":"2014","unstructured":"Buscarlet M, Krasteva V, Ho L, Simon C, H\u00e9bert J, Wilhelm B, et al. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood. 2014;123:1720\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24478402\/ [cited 3 Oct 2022].","journal-title":"Blood"},{"key":"1736_CR88","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/1541-7786.MCR-21-0390","volume":"20","author":"F Rago","year":"2022","unstructured":"Rago F, Rodrigues LU, Bonney M, Sprouffske K, Kurth E, Elliott GN, et al. Exquisite Sensitivity to Dual BRG1\/BRM ATPase Inhibitors Reveals Broad SWI\/SNF Dependencies in Acute Myeloid Leukemia. Mol Cancer Res. 2022;20:361\u201372 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34799403\/ [cited 14 Sep 2022].","journal-title":"Mol Cancer Res"},{"key":"1736_CR89","doi-asserted-by":"crossref","unstructured":"Ren T, Wang J, Tang W, Chen D, Wang S, Zhang X, et al. ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-\u03b21\/SMAD3 signaling. Clin Exp Med. 2022.\u00a0Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35867200\/. [cited 16 Sep 2022].","DOI":"10.1007\/s10238-022-00863-8"},{"key":"1736_CR90","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1535-6108(02)00185-X","volume":"2","author":"CWM Roberts","year":"2002","unstructured":"Roberts CWM, Leroux MM, Fleming MD, Orkin SH. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell. 2002;2:415\u201325 Cell Press.","journal-title":"Cancer Cell"},{"key":"1736_CR91","first-page":"3870","volume":"59","author":"F Grand","year":"1999","unstructured":"Grand F, Kulkarni S, Chase A, Goldman JM, Gordon M, Cross NC. Frequent Deletion of hSNF5\/INI1, a Component of the SWI\/SNF Complex, in Chronic Myeloid Leukemia. Cancer Res. 1999;59:3870\u20134 Available from: https:\/\/aacrjournals.org\/cancerres\/article\/59\/16\/3870\/505411\/Frequent-Deletion-of-hSNF5-INI1-a-Component-of-the [cited 4 Oct 2022].","journal-title":"Cancer Res"},{"key":"1736_CR92","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/1541-7786.MCR-17-0493","volume":"16","author":"SS Chatterjee","year":"2018","unstructured":"Chatterjee SS, Biswas M, Boila LD, Banerjee D, Sengupta A. SMARCB1 Deficiency integrates epigenetic signals to oncogenic gene expression program maintenance in human acute myeloid leukemia. Mol Cancer Res. 2018;16:791\u2013804 American Association for Cancer Research Inc. Available from: https:\/\/aacrjournals.org\/mcr\/article\/16\/5\/791\/89912\/SMARCB1-Deficiency-Integrates-Epigenetic-Signals [cited 4 Oct 2022].","journal-title":"Mol Cancer Res"},{"key":"1736_CR93","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1182\/blood.V98.12.3413","volume":"98","author":"E Satterwhite","year":"2001","unstructured":"Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood. 2001;98:3413\u201320 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/98\/12\/3413\/53221\/The-BCL11-gene-family-involvement-of-BCL11A-in [cited 16 Sep 2022].","journal-title":"Blood"},{"key":"1736_CR94","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/bloodadvances.2021004558","volume":"6","author":"Y Sunami","year":"2022","unstructured":"Sunami Y, Yokoyama T, Yoshino S, Takahara T, Yamazaki Y, Harada H, et al. BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes. Blood Adv. 2022;6:1827\u201343.","journal-title":"Blood Adv"},{"key":"1736_CR95","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1182\/blood-2008-03-144436","volume":"113","author":"B Yin","year":"2009","unstructured":"Yin B, Delwel R, Valk PJ, Wallace MR, Loh ML, Shannon KM, et al. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood. 2009;113:1075\u201385 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18948576\/ [cited 16 Sep 2022].","journal-title":"Blood"},{"key":"1736_CR96","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3389\/fphar.2020.00820","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi H, Li C, Feng W, Yue J, Song J, Peng A, et al. BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer\/T-Cell Lymphoma. Front Pharmacol. 2020;11:820 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32625084\/ [cited 16 Sep 2022].","journal-title":"Front Pharmacol"},{"key":"1736_CR97","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1349-7006.2009.01172.x","volume":"100","author":"A Nagamachi","year":"2009","unstructured":"Nagamachi A, Yamasaki N, Miyazaki K, Oda H, Miyazaki M, Honda Z, et al. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model. Cancer Sci. 2009;100:1219\u201326 Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01172.x [cited 2 Nov 2022].","journal-title":"Cancer Sci"},{"key":"1736_CR98","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","volume":"118","author":"A Gutierrez","year":"2011","unstructured":"Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen S-C, Zhang J, et al. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood. 2011;118:4169\u201373.","journal-title":"Blood."},{"key":"1736_CR99","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","volume":"11","author":"LE Montefiori","year":"2021","unstructured":"Montefiori LE, Bendig S, Gu Z, Chen X, P\u00f6l\u00f6nen P, Ma X, et al. Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia. Cancer Discov. 2021;11:2846\u201367.","journal-title":"Cancer Discov"},{"key":"1736_CR100","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1182\/blood-2021-150841","volume":"138","author":"D di Giacomo","year":"2021","unstructured":"di Giacomo D, la Starza R, Gorello P, Pellanera F, Kalender Atak Z, de Keersmaecker K, et al. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T and myeloid immature acute leukemia. Blood. 2021;138:773\u201384.","journal-title":"Blood."},{"issue":"7","key":"1736_CR101","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41408-022-00704-7","volume":"12","author":"E Weisberg","year":"2022","unstructured":"Weisberg E, Chowdhury B, Meng C, Case AE, Ni W, Garg S, et al. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma. Blood Cancer J. 2022;12(7):110.","journal-title":"Blood Cancer J."},{"key":"1736_CR102","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nchembio.2115","volume":"12","author":"AF Hohmann","year":"2016","unstructured":"Hohmann AF, Martin LJ, Minder JL, Roe JS, Shi J, Steurer S, et al. Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition. Nat Chem Biol. 2016;12:672\u20139 Nat Publ Group.","journal-title":"Nat Chem Biol"},{"issue":"22","key":"1736_CR103","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/onc.2016.470","volume":"36","author":"A Ugale","year":"2017","unstructured":"Ugale A, S\u00e4w\u00e9n P, Dudenh\u00f6ffer-Pfeifer M, Wahlestedt M, Norddahl GL, Bryder D. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment. Oncogene. 2017;36(22):3207\u201312 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/onc2016470 [cited 2022 Aug 10].","journal-title":"Oncogene"},{"key":"1736_CR104","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1128\/MCB.23.8.2942-2952.2003","volume":"23","author":"Z Nie","year":"2003","unstructured":"Nie Z, Yan Z, Chen EH, Sechi S, Ling C, Zhou S, et al. Novel SWI\/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol Cell Biol. 2003;23:2942\u201352 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12665591\/ [cited 10 Aug 2022].","journal-title":"Mol Cell Biol"},{"key":"1736_CR105","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cell.2018.05.048","volume":"174","author":"JA Pulikkan","year":"2018","unstructured":"Pulikkan JA, Hegde M, Ahmad HM, Belaghzal H, Illendula A, Yu J, et al. CBF\u03b2-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018;174:172\u2013186.e21 Cell Press. Available from: http:\/\/www.cell.com\/article\/S0092867418307098\/fulltext [cited 23 Jan 2023].","journal-title":"Cell"},{"key":"1736_CR106","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ygeno.2005.03.013","volume":"86","author":"D Wilsker","year":"2005","unstructured":"Wilsker D, Probst L, Wain HM, Maltais L, Tucker PW, Moran E. Nomenclature of the ARID family of DNA-binding proteins. Genomics. 2005;86:242\u201351 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15922553\/ [cited 3 Oct 2022].","journal-title":"Genomics"},{"key":"1736_CR107","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/cbin.10332","volume":"38","author":"H Wu","year":"2014","unstructured":"Wu H, Gao Y, Ding L, He D, Li Y. Gene expression profile analysis of SUDHL6 cells with siRNA-mediated BCL11A downregulation. Cell Biol Int. 2014;38:1205\u201314 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25044937\/ [cited 19 Oct 2022].","journal-title":"Cell Biol Int"},{"key":"1736_CR108","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3324\/haematol.2020.274258","volume":"107","author":"MCJ Ma","year":"2022","unstructured":"Ma MCJ, Tadros S, Bouska A, Heavican T, Yang H, Deng Q, et al. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma. Haematologica. 2022;107:690\u2013701 Ferrata Storti Foundation. Available from: https:\/\/haematologica.org\/article\/view\/haematol.2020.274258 [cited 15 Jul 2022].","journal-title":"Haematologica"},{"key":"1736_CR109","doi-asserted-by":"crossref","unstructured":"McKinney M, Moffitt AB, Gaulard P, Travert M, de Leval L, Raffeld ANM, et al. The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov. 2017;7:369\u201379. American Association for Cancer Research Inc.\u00a0Available from: https:\/\/aacrjournals.org\/cancerdiscovery\/article\/7\/4\/369\/5954\/The-Genetic-Basis-of-Hepatosplenic-T-cell. [cited 21 Jul 2022].","DOI":"10.1158\/2159-8290.CD-16-0330"},{"issue":"12","key":"1736_CR110","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","volume":"33","author":"Y Watatani","year":"2019","unstructured":"Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, et al. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019;33(12):2867\u201383 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-019-0473-1 [cited 19 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR111","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3324\/haematol.2018.202093","volume":"104","author":"MR Sapienza","year":"2019","unstructured":"Sapienza MR, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, et al. Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target. Haematologica. 2019;104:729\u201337 Ferrata Storti Foundation. Available from: https:\/\/haematologica.org\/article\/view\/8847 [cited 25 Jul 2022].","journal-title":"Haematologica"},{"key":"1736_CR112","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"SM Sweeney","year":"2017","unstructured":"Sweeney SM, Cerami E, Baras A, Pugh TJ, Schultz N, Stricker T, et al. AACR project genie: Powering precision medicine through an international consortium. Cancer Discov. 2017;7:818\u201331 American Association for Cancer Research Inc. Available from: https:\/\/aacrjournals.org\/cancerdiscovery\/article\/7\/8\/818\/6485\/AACR-Project-GENIE-Powering-Precision-Medicine [cited 12 Jul 2022].","journal-title":"Cancer Discov"},{"issue":"4","key":"1736_CR113","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","volume":"37","author":"J Zhang","year":"2019","unstructured":"Zhang J, Bajari R, Andric D, Gerthoffert F, Lepsa A, Nahal-Bose H, et al. The International Cancer Genome Consortium Data Portal. Nat Biotechnol. 2019;37(4):367\u20139 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41587-019-0055-9 [cited 18 Jul 2022].","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1736_CR114","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45(6):592\u2013601 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.2628 [cited 28 Jul 2022].","journal-title":"Nat Genet"},{"key":"1736_CR115","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1182\/blood.2021011708","volume":"139","author":"A Andrades","year":"2022","unstructured":"Andrades A, \u00c1lvarez-P\u00e9rez JC, Pati\u00f1o-Mercau JR, Cuadros M, Bali\u00f1as-Gavira C, Medina PP. Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes. Blood. 2022;139:2406\u201310 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/139\/15\/2406\/483332\/Recurrent-splice-site-mutations-affect-key-diffuse [cited 28 Jul 2022].","journal-title":"Blood"},{"issue":"7","key":"1736_CR116","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","volume":"17","author":"P Mittal","year":"2020","unstructured":"Mittal P, Roberts CWM. The SWI\/SNF complex in cancer \u2014 biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17(7):435\u201348 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41571-020-0357-3 [cited 10 Jan 2023].","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1736_CR117","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13148-022-01261-3","volume":"14","author":"P Peinado","year":"2022","unstructured":"Peinado P, Andrades A, Cuadros M, Rodriguez MI, Coira IF, Garcia DJ, et al. Multi-omic alterations of the SWI\/SNF complex define a clinical subgroup in lung adenocarcinoma. Clin Epigenetics. 2022;14(1):42.","journal-title":"Clin Epigenetics."},{"key":"1736_CR118","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41594-017-0007-3","volume":"25","author":"HC Hodges","year":"2018","unstructured":"Hodges HC, Stanton BZ, Cermakova K, Chang C-Y, Miller EL, Kirkland JG, et al. Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers. Nat Struct Mol Biol. 2018;25:61\u201372. https:\/\/doi.org\/10.1038\/s41594-017-0007-3.","journal-title":"Nat Struct Mol Biol"},{"key":"1736_CR119","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","volume":"11","author":"TM Fernando","year":"2020","unstructured":"Fernando TM, Piskol R, Bainer R, Sokol ES, Trabucco SE, Zhang Q, et al. Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients. Nat Commun. 2020;11:5551. https:\/\/doi.org\/10.1038\/s41467-020-19402-8.","journal-title":"Nat Commun"},{"key":"1736_CR120","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I, Raine KM, Gerstung M, Dawson KJ, Haase K, van Loo P, et al. Universal patterns of selection in Cancer and somatic tissues. Cell. 2017;171:1029\u20131041.e21. https:\/\/doi.org\/10.1016\/j.cell.2017.09.042 Elsevier.","journal-title":"Cell"},{"key":"1736_CR121","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, et al. Genetics of Follicular Lymphoma Transformation. Cell Rep. 2014;6:130\u201340 Elsevier. Available from: http:\/\/www.cell.com\/article\/S2211124713007857\/fulltext [cited 14 Jul 2022].","journal-title":"Cell Rep"},{"key":"1736_CR122","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.2019001880","volume":"134","author":"RI Panea","year":"2019","unstructured":"Panea RI, Love CL, Shingleton JR, Reddy A, Bailey JA, Moormann AM, et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood. 2019;134:1598\u2013607 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/134\/19\/1598\/375002\/The-whole-genome-landscape-of-Burkitt-lymphoma [cited 11 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR123","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood-2019-129155","volume":"134","author":"C Chakraborty","year":"2019","unstructured":"Chakraborty C, Morelli E, Linares M, Anderson KC, Samur MK, Fulciniti M, et al. Recurrent Non-Coding Mutations in BCL7A May Have Significant Functional Consequence in Multiple Myeloma. Blood. 2019;134:857 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/134\/Supplement_1\/857\/427069\/Recurrent-Non-Coding-Mutations-in-BCL7A-May-Have [cited 15 Jul 2022].","journal-title":"Blood"},{"issue":"7","key":"1736_CR124","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","volume":"35","author":"D H\u00fcbschmann","year":"2021","unstructured":"H\u00fcbschmann D, Kleinheinz K, Wagener R, Bernhart SH, L\u00f3pez C, Toprak UH, et al. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021;35(7):2002\u201316 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-021-01251-z [cited 28 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR125","doi-asserted-by":"crossref","unstructured":"Bal E, Kumar R, Hadigol M, Holmes AB, Hilton LK, Loh JW, et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. 2022;607:808\u201315. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/s41586-022-04906-8. [cited 8 Jul 2022].","DOI":"10.1038\/s41586-022-04906-8"},{"key":"1736_CR126","doi-asserted-by":"publisher","first-page":"BSR20190604","DOI":"10.1042\/BSR20190604","volume":"39","author":"J Yin","year":"2019","unstructured":"Yin J, Xie X, Ye Y, Wang L, Che F. BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases. Biosci Rep. 2019;39:BSR20190604 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31654056\/ [cited 31 Oct 2022].","journal-title":"Biosci Rep"},{"key":"1736_CR127","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","volume":"99","author":"JI Mart\u00edn-Subero","year":"2002","unstructured":"Mart\u00edn-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood. 2002;99:1474\u20137 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/99\/4\/1474\/110037\/Recurrent-involvement-of-the-REL-and-BCL11Aloci-in [cited 26 Jul 2022].","journal-title":"Blood"},{"issue":"10","key":"1736_CR128","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/sj.leu.2404324","volume":"20","author":"MA Weniger","year":"2006","unstructured":"Weniger MA, Pulford K, Gesk S, Ehrlich S, Banham AH, Lyne L, et al. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11AXL protein are frequent in primary mediastinal B-cell lymphoma. Leukemia. 2006;20(10):1880\u20132 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/2404324 [cited 26 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR129","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","volume":"106","author":"S Bea","year":"2005","unstructured":"Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 2005;106:3183\u201390 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/106\/9\/3183\/21944\/Diffuse-large-B-cell-lymphoma-subgroups-have [cited 26 Jul 2022].","journal-title":"Blood"},{"issue":"3","key":"1736_CR130","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/leu.2017.251","volume":"32","author":"K Karube","year":"2018","unstructured":"Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, et al. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia. 2018;32(3):675\u201384 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/leu2017251 [cited 26 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR131","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/gcc.22184","volume":"53","author":"A Kwiecinska","year":"2014","unstructured":"Kwiecinska A, Ichimura K, Berglund M, Dinets A, Sulaiman L, Collins VP, et al. Amplification of 2p as a genomic marker for transformation in lymphoma. Genes Chromosom Cancer. 2014;53:750\u201368 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/gcc.22184 [cited 26 Jul 2022].","journal-title":"Genes Chromosom Cancer"},{"key":"1736_CR132","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3324\/haematol.2019.227892","volume":"105","author":"CR Bolen","year":"2020","unstructured":"Bolen CR, Klanova M, Trn\u00e9ny M, Sehn LH, He J, Tong J, et al. Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study. Haematologica. 2020;105:2298\u2013307 Ferrata Storti Foundation. Available from: https:\/\/haematologica.org\/article\/view\/9561 [cited 25 Jul 2022].","journal-title":"Haematologica"},{"key":"1736_CR133","doi-asserted-by":"publisher","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","volume":"112","author":"MR Green","year":"2015","unstructured":"Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci U S A. 2015;112:E1116\u201325 National Academy of Sciences. Available from: www.pnas.org\/cgi\/doi\/10.1073\/pnas.1501199112 [cited 15 Jul 2022].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1736_CR134","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","volume":"129","author":"K Krysiak","year":"2017","unstructured":"Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, et al. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 2017;129:473\u201383 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/129\/4\/473\/36199\/Recurrent-somatic-mutations-affecting-B-cell [cited 14 Jul 2022].","journal-title":"Blood"},{"issue":"1","key":"1736_CR135","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C L\u00f3pez","year":"2019","unstructured":"L\u00f3pez C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, H\u00fcbschmann D, et al. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun. 2019;10(1):1459.","journal-title":"Nat Commun."},{"issue":"12","key":"1736_CR136","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44(12):1321\u20135 Available from: https:\/\/www.nature.com\/articles\/ng.2468. Nature Publishing Group [cited 11 Jul 2022].","journal-title":"Nat Genet"},{"issue":"7418","key":"1736_CR137","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490(7418):116\u201320 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/nature11378 [cited 11 Jul 2022].","journal-title":"Nature"},{"key":"1736_CR138","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","volume":"15","author":"Y Kaymaz","year":"2017","unstructured":"Kaymaz Y, Oduor CI, Yu H, Otieno JA, Ong\u2019echa JM, Moormann AM, et al. Comprehensive transcriptome and mutational profiling of Endemic Burkitt lymphoma reveals EBV type-specific differences. Mol Cancer Res. 2017;15:563\u201376 American Association for Cancer Research Inc. Available from: https:\/\/aacrjournals.org\/mcr\/article\/15\/5\/563\/281647\/Comprehensive-Transcriptome-and-Mutational [cited 15 Jul 2022].","journal-title":"Mol Cancer Res"},{"key":"1736_CR139","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","volume":"131","author":"V Spina","year":"2018","unstructured":"Spina V, Bruscaggin A, Cuccaro A, Martini M, di Trani M, Forestieri G, et al. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. Blood. 2018;131:2413\u201325 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/131\/22\/2413\/37097\/Circulating-tumor-DNA-reveals-genetics-clonal [cited 12 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR140","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, et al. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019;3:4065\u201380 American Society of Hematology. Available from: https:\/\/ashpublications.org\/bloodadvances\/article\/3\/23\/4065\/429586\/Genomic-analyses-of-flow-sorted-Hodgkin-Reed [cited 12 Jul 2022].","journal-title":"Blood Adv"},{"key":"1736_CR141","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.2019001126","volume":"134","author":"A Mottok","year":"2019","unstructured":"Mottok A, Hung SS, Chavez EA, Woolcock B, Telenius A, Chong LC, et al. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood. 2019;134:802\u201313 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/134\/10\/802\/260637\/Integrative-genomic-analysis-identifies-key [cited 12 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR142","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Be\u00e0","year":"2013","unstructured":"Be\u00e0 S, Vald\u00e9s-Mas R, Navarro A, Salaverria I, Mart\u00edn-Garcia D, Jares P, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A. 2013;110:18250\u20135 PNAS. Available from: www.pnas.org\/lookup\/suppl\/doi:10.1073\/pnas.1314608110\/-\/DCSupplemental.www.pnas.org\/cgi\/doi\/10.1073\/pnas.1314608110 [cited 12 Jul 2022].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1736_CR143","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","volume":"123","author":"J Zhang","year":"2014","unstructured":"Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, et al. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood. 2014;123:2988\u201396 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/123\/19\/2988\/32656\/The-genomic-landscape-of-mantle-cell-lymphoma-is [cited 12 Jul 2022].","journal-title":"Blood"},{"issue":"1","key":"1736_CR144","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1038\/s41598-019-46906-1","volume":"9","author":"C Jaramillo Oquendo","year":"2019","unstructured":"Jaramillo Oquendo C, Parker H, Oscier D, Ennis S, Gibson J, Strefford JC. Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma. Sci Rep. 2019;9(1):10444.","journal-title":"Sci Rep."},{"key":"1736_CR145","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","volume":"480","author":"V Vela","year":"2022","unstructured":"Vela V, Juskevicius D, Dirnhofer S, Menter T, Tzankov A. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch. 2022;480:403\u201313 Springer Science and Business Media Deutschland GmbH. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03186-3 [cited 14 Jul 2022].","journal-title":"Virchows Arch"},{"key":"1736_CR146","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","volume":"21","author":"M Parry","year":"2015","unstructured":"Parry M, Rose-Zerilli MJJ, Ljungstr\u00f6m V, Gibson J, Wang J, Walewska R, et al. Genetics and prognostication in splenic marginal zone lymphoma: Revelations from deep sequencing. Clin Cancer Res. 2015;21:4174\u201383 American Association for Cancer Research Inc. Available from: https:\/\/aacrjournals.org\/clincancerres\/article\/21\/18\/4174\/117432\/Genetics-and-Prognostication-in-Splenic-Marginal [cited 14 Jul 2022].","journal-title":"Clin Cancer Res"},{"key":"1736_CR147","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","volume":"102","author":"M Varettoni","year":"2017","unstructured":"Varettoni M, Zibellini S, Defrancesco I, Ferretti VV, Rizzo E, Malcovati L, et al. Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. Haematologica. 2017;102:2077\u201385.","journal-title":"Haematologica."},{"key":"1736_CR148","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","volume":"123","author":"ZR Hunter","year":"2014","unstructured":"Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. The genomic landscape of Waldenstr\u00f6m macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014;123:1637\u201346 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/123\/11\/1637\/105746\/The-genomic-landscape-of-Waldenstrom [cited 2022 Jul 19].","journal-title":"Blood"},{"key":"1736_CR149","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019;133:1664\u201376 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/133\/15\/1664\/273305\/Genetic-drivers-of-oncogenic-pathways-in-molecular [cited 19 Jul 2022].","journal-title":"Blood"},{"issue":"1","key":"1736_CR150","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/leu.2014.261","volume":"29","author":"JH Schatz","year":"2015","unstructured":"Schatz JH, Horwitz SM, Teruya-Feldstein J, Lunning MA, Viale A, Huberman K, et al. Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis. Leukemia. 2015;29(1):237\u201341 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/leu2014261 [cited 21 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR151","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3324\/haematol.2017.182444","volume":"103","author":"MM Ji","year":"2018","unstructured":"Ji MM, Huang YH, Huang JY, Wang ZF, Fu D, Liu H, et al. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. Haematologica. 2018;103:679\u201387.","journal-title":"Haematologica."},{"issue":"9","key":"1736_CR152","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","volume":"47","author":"J Choi","year":"2015","unstructured":"Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015;47(9):1011\u20139 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3356 [cited 20 Jul 2022].","journal-title":"Nat Genet"},{"issue":"12","key":"1736_CR153","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/ng.3442","volume":"47","author":"AC da Silva Almeida","year":"2015","unstructured":"da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, et al. The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome. Nat Genet. 2015;47(12):1465\u201370 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3442 [cited 20 Jul 2022].","journal-title":"Nat Genet"},{"key":"1736_CR154","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood.2020009655","volume":"138","author":"J Park","year":"2021","unstructured":"Park J, Daniels J, Wartewig T, Ringbloom KG, Martinez-Escala ME, Choi S, et al. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity. Blood. 2021;138:1225\u201336.","journal-title":"Blood."},{"issue":"12","key":"1736_CR155","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ng.3444","volume":"47","author":"L Wang","year":"2015","unstructured":"Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, et al. Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015;47(12):1426\u201334 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3444 [cited 20 Jul 2022].","journal-title":"Nat Genet"},{"key":"1736_CR156","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","volume":"130","author":"J Park","year":"2017","unstructured":"Park J, Yang J, Wenzel AT, Ramachandran A, Lee WJ, Daniels JC, et al. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). Blood. 2017;130:1430\u201340 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/130\/12\/1430\/36502\/Genomic-analysis-of-220-CTCLs-identifies-a-novel [cited 20 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR157","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1158\/2159-8290.CD-21-1207","volume":"12","author":"X Song","year":"2022","unstructured":"Song X, Chang S, Seminario-Vidal L, de Mingo PA, Tordesillas L, Song X, et al. Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma. Cancer Discov. 2022;12:1294\u2013313 NLM (Medline). Available from: https:\/\/aacrjournals.org\/cancerdiscovery\/article\/12\/5\/1294\/694564\/Genomic-and-Single-Cell-Landscape-Reveals-Novel [cited 20 Jul 2022].","journal-title":"Cancer Discov"},{"key":"1736_CR158","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/gcc.20601","volume":"47","author":"A Carbone","year":"2008","unstructured":"Carbone A, Bernardini L, Valenzano F, Bottillo I, de Simone C, Capizzi R, et al. Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC\/DIABLO, and RHOF. Genes Chromosom Cancer. 2008;47:1067\u201375 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/gcc.20601 [cited 10 Jul 2022].","journal-title":"Genes Chromosom Cancer"},{"key":"1736_CR159","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5808\/GI.2016.14.3.78","volume":"14","author":"S Choi","year":"2016","unstructured":"Choi S, Go JH, Kim EK, Lee H, Lee WM, Cho C-S, et al. Mutational analysis of extranodal NK\/T-cell lymphoma using targeted sequencing with a comprehensive cancer panel. Genomics Inform. 2016;14:78\u201384.","journal-title":"Genomics Inform."},{"key":"1736_CR160","doi-asserted-by":"crossref","unstructured":"Koo GC, Tan SY, Tang T, Poon SL, Allen GE, Tan L, et al. Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma. Cancer Discov. 2012;2:591\u20137. American Association for Cancer Research.\u00a0Available from: https:\/\/aacrjournals.org\/cancerdiscovery\/article\/2\/7\/591\/3362\/Janus-Kinase-3-Activating-Mutations-Identified-in. [cited 20 Jul 2022].","DOI":"10.1158\/2159-8290.CD-12-0028"},{"key":"1736_CR161","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","volume":"6","author":"S Lee","year":"2015","unstructured":"Lee S, Park HY, Kang SY, Kim SJ, Hwang J, Lee S, et al. Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type. Oncotarget. 2015;6:17764\u201376 Impact Journals. Available from: https:\/\/www.oncotarget.com\/article\/3776\/text\/ [cited 20 Jul 2022].","journal-title":"Oncotarget"},{"key":"1736_CR162","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/gcc.22348","volume":"55","author":"A Dobashi","year":"2016","unstructured":"Dobashi A, Tsuyama N, Asaka R, Togashi Y, Ueda K, Sakata S, et al. Frequent BCOR aberrations in extranodal NK\/T-cell lymphoma, nasal type. Genes Chromosom Cancer. 2016;55:460\u201371 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/gcc.22348 [cited 20 Jul 2022].","journal-title":"Genes Chromosom Cancer"},{"issue":"9","key":"1736_CR163","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu ZH, Yan ZX, Zhao X, Xie YY, Zhang ZG, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet. 2015;47(9):1061\u20136 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3358 [cited 20 Jul 2022].","journal-title":"Nat Genet"},{"key":"1736_CR164","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20160894","volume":"214","author":"AB Moffitt","year":"2017","unstructured":"Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, et al. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med. 2017;214:1371\u201386. https:\/\/doi.org\/10.1084\/jem.20160894 The Rockefeller University Press [cited 21 Jul 2022].","journal-title":"J Exp Med"},{"issue":"7696","key":"1736_CR165","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature25795","volume":"555","author":"X Ma","year":"2018","unstructured":"Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature. 2018;555(7696):371\u20136 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/nature25795 [cited 18 Jan 2023].","journal-title":"Nature"},{"key":"1736_CR166","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet. 2022;54:1376\u201389 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36050548\/ [cited 20 Oct 2022].","journal-title":"Nat Genet"},{"issue":"8","key":"1736_CR167","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49(8):1211\u20138 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3909 [cited 18 Jan 2023].","journal-title":"Nat Genet"},{"key":"1736_CR168","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/gcc.1141","volume":"31","author":"J Soulier","year":"2001","unstructured":"Soulier J, Pierron G, Vecchione D, Garand R, Brizard F, Sigaux F, et al. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosom Cancer. 2001;31:248\u201354 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/gcc.1141 [cited 16 Jan 2023].","journal-title":"Genes Chromosom Cancer"},{"key":"1736_CR169","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cancergencyto.2009.03.001","volume":"192","author":"S Bug","year":"2009","unstructured":"Bug S, D\u00fcrig J, Oyen F, Klein-Hitpass L, Martin-Subero JI, Harder L, et al. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A\u2013TCRAD juxtaposition. Cancer Genet Cytogenet. 2009;192:44\u20137 Elsevier.","journal-title":"Cancer Genet Cytogenet"},{"key":"1736_CR170","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/10428190310001623900","volume":"45","author":"G Specchia","year":"2004","unstructured":"Specchia G, Albano F, Anelli L, Storlazzi CT, Zagaria A, Liso A, et al. Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes. Leuk Lymphoma. 2004;45:689\u201394.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1736_CR171","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/leu.2017.319","volume":"32","author":"H Sakai","year":"2018","unstructured":"Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway HE, et al. A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. Leukemia. 2018;32(3):839\u201343 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/leu2017319 [cited 22 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR172","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bjh.17795","volume":"196","author":"H Yao","year":"2022","unstructured":"Yao H, Huo L, Ping N, Liu H, Li H, Ding Z, et al. Recurrent mutations in multiple components of the SWI\/SNF complex in myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol. 2022;196:441\u20134 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/bjh.17795 [cited 22 Jul 2022].","journal-title":"Br J Haematol"},{"issue":"4","key":"1736_CR173","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/leu.2013.283","volume":"28","author":"J Menezes","year":"2014","unstructured":"Menezes J, Acquadro F, Wiseman M, G\u00f3mez-L\u00f3pez G, Salgado RN, Talavera-Casa\u00f1as JG, et al. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia. 2014;28(4):823\u20139 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/leu2013283 [cited 25 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR174","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1182\/blood.V122.21.741.741","volume":"122","author":"J Taylor","year":"2013","unstructured":"Taylor J, Kim SS, Stevenson KE, Yoda A, Kopp N, Louissaint A, et al. Loss-of-function mutations in the splicing factor ZRSR2 are common in Blastic Plasmacytoid dendritic cell neoplasm and have male predominance. Blood. 2013;122:741.","journal-title":"Blood."},{"key":"1736_CR175","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-20-1513","volume":"12","author":"K Togami","year":"2022","unstructured":"Togami K, Chung SS, Madan V, Booth CAG, Kenyon CM, Cabal-Hierro L, et al. Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis. Cancer Discov. 2022;12:522\u201341 American Association for Cancer Research Inc. Available from: https:\/\/aacrjournals.org\/cancerdiscovery\/article\/12\/2\/522\/678508\/Sex-Biased-ZRSR2-Mutations-in-Myeloid-Malignancies [cited 25 Jul 2022].","journal-title":"Cancer Discov"},{"key":"1736_CR176","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.3324\/haematol.2017.172742","volume":"102","author":"L Wang","year":"2017","unstructured":"Wang L, Yang M, Zhang X, Yang C, Huang X, Wang Z, et al. ARID1A mutation in blastic plasmacytoid dendritic cell neoplasm. Haematologica. 2017;102:e470\u20132 Ferrata Storti Foundation. Available from: https:\/\/haematologica.org\/article\/view\/8271 [cited 25 Jul 2022].","journal-title":"Haematologica"},{"key":"1736_CR177","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","volume":"16","author":"A Pastore","year":"2015","unstructured":"Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015;16:1111\u201322 Elsevier. Available from: http:\/\/www.thelancet.com\/article\/S1470204515001692\/fulltext [cited 14 Jul 2022].","journal-title":"Lancet Oncol"},{"key":"1736_CR178","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1182\/blood.V87.8.3124.bloodjournal8783124","volume":"87","author":"VJ Zani","year":"1996","unstructured":"Zani VJ, Asou N, Jadayel D, Heward JM, Shipley J, Nacheva E, et al. Molecular Cloning of Complex Chromosomal Translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt Lymphoma Cell Line Defines a New Gene (BCL7A) With Homology to Caldesmon. Blood. 1996;87:3124\u201334.","journal-title":"Blood."},{"issue":"5","key":"1736_CR179","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","volume":"24","author":"J Shen","year":"2018","unstructured":"Shen J, Ju Z, Zhao W, Wang L, Peng Y, Ge Z, et al. ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nat Med. 2018;24(5):556\u201362 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41591-018-0012-z [cited 12 Jul 2022].","journal-title":"Nat Med"},{"key":"1736_CR180","doi-asserted-by":"crossref","unstructured":"Mata E, Fern\u00e1ndez S, Astudillo A, Fern\u00e1ndez R, Garc\u00eda-Cos\u00edo M, S\u00e1nchez-Beato M, et al. Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma. Blood Cancer J. 2019;9(3):34. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/s41408-019-0195-7. [cited 12 Jul 2022].","DOI":"10.1038\/s41408-019-0195-7"},{"key":"1736_CR181","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","volume":"125","author":"J Reichel","year":"2015","unstructured":"Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2015;125:1061\u201372 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/125\/7\/1061\/34180\/Flow-sorting-and-exome-sequencing-reveal-the [cited 12 Jul 2022].","journal-title":"Blood"},{"issue":"4","key":"1736_CR182","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/leu.2015.328","volume":"30","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Schuhmacher B, Rausch T, Fuller L, D\u00f6ring C, Weniger M, et al. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia. 2016;30(4):844\u201353 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/leu2015328 [cited 12 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR183","first-page":"1463","volume":"130","author":"JY Song","year":"2017","unstructured":"Song JY, Egan C, Gong Q, Venkataraman G, Herrera AF, Ottesen R, et al. Mutation Spectrum of transformed nodular lymphocyte predominant Hodgkin lymphoma and comparison with De novo diffuse large B-cell lymphoma. Blood. 2017;130:1463.","journal-title":"Blood."},{"key":"1736_CR184","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood.2019002067","volume":"134","author":"B Chapuy","year":"2019","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Wienand K, Kamburov A, et al. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. Blood. 2019;134:2369\u201382 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/134\/26\/2369\/422650\/Genomic-analyses-of-PMBL-reveal-new-drivers-and [cited 12 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR185","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","volume":"113","author":"R van Doorn","year":"2009","unstructured":"van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K, et al. Oncogenomic analysis of mycosis fungoides reveals major differences with S\u00e9zary syndrome. Blood. 2009;113:127\u201336 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/113\/1\/127\/24416\/Oncogenomic-analysis-of-mycosis-fungoides-reveals [cited 20 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR186","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123:1293\u20136 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/123\/9\/1293\/32919\/A-targeted-mutational-landscape-of [cited 21 Jul 2022].","journal-title":"Blood"},{"issue":"4","key":"1736_CR187","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371\u20135 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.2916 [cited 21 Jul 2022].","journal-title":"Nat Genet"},{"key":"1736_CR188","doi-asserted-by":"publisher","first-page":"e66395","DOI":"10.7554\/eLife.66395","volume":"10","author":"S Cheng","year":"2021","unstructured":"Cheng S, Zhang W, Inghirami G, Tam W. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking. Elife. 2021;10:e66395 eLife Sciences Publications Ltd.","journal-title":"Elife"},{"key":"1736_CR189","doi-asserted-by":"crossref","unstructured":"Butzmann A, Sridhar K, Jangam D, Song H, Singh A, Kumar J, et al. Mutations in JAK\/STAT and NOTCH1 genes are enriched in post-transplant Lymphoproliferative disorders. Front Oncol. 2022;11:790481.","DOI":"10.3389\/fonc.2021.790481"},{"key":"1736_CR190","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","volume":"128","author":"D Vallois","year":"2016","unstructured":"Vallois D, Dobay MPD, Morin RD, Lemonnier F, Missiaglia E, Juilland M, et al. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell\u2013derived lymphomas. Blood. 2016;128:1490\u2013502 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/128\/11\/1490\/35240\/Activating-mutations-in-genes-related-to-TCR [cited 22 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR191","doi-asserted-by":"crossref","unstructured":"Roberti A, Dobay MP, Bisig B, Vallois D, Bo\u00e9chat C, Lanitis E, et al. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun. 2016;7(1):12602. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/ncomms12602. [cited 21 Jul 2022].","DOI":"10.1038\/ncomms12602"},{"key":"1736_CR192","doi-asserted-by":"crossref","unstructured":"Chen C, Gong Y, Yang Y, Xia Q, Rao Q, Shao Y, et al. Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases. Diagn Pathol. 2021;16:114. BioMed Central Ltd.\u00a0Available from: https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01173-5. [cited 21 Jul 2022].","DOI":"10.1186\/s13000-021-01173-5"},{"key":"1736_CR193","doi-asserted-by":"crossref","unstructured":"Veloza L, Cavalieri D, Missiaglia E, Ledoux-Pilon A, Bisig B, Pereira B, et al. Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. Haematologica. 2023;108:1. Ferrata Storti Foundation (Haematologica).\u00a0Available from: https:\/\/haematologica.org\/article\/view\/haematol.2022.281226. [cited 21 Jul 2022].","DOI":"10.3324\/haematol.2022.281226"},{"key":"1736_CR194","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","volume":"27","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo R, Abate F, Lasorsa E, Tabbo\u2019 F, Gaudiano M, Chiesa N, et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 2015;27:516\u201332 Cell Press. Available from: http:\/\/www.cell.com\/article\/S153561081500094X\/fulltext [cited 21 Jul 2022].","journal-title":"Cancer Cell"},{"issue":"5","key":"1736_CR195","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","volume":"35","author":"C Lobello","year":"2020","unstructured":"Lobello C, Tichy B, Bystry V, Radova L, Filip D, Mraz M, et al. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia. 2020;35(5):1500\u20135 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-020-01093-1 [cited 21 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR196","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1182\/blood.2019000626","volume":"133","author":"RA Luchtel","year":"2019","unstructured":"Luchtel RA, Zimmermann MT, Hu G, Dasari S, Jiang M, Oishi N, et al. Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma. Blood. 2019;133:2776\u201389 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/133\/26\/2776\/272770\/Recurrent-MSCE116K-mutations-in-ALK-negative [cited 21 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR197","doi-asserted-by":"publisher","first-page":"128","DOI":"10.21037\/atm-20-7574","volume":"9","author":"L-H Zhong","year":"2021","unstructured":"Zhong L-H, Wu Z-D, Wang J-C, Wu Z-Z, Chen F-F, Zhu W-F, et al. Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity. Ann Transl Med. 2021;9:128 AME Publishing Company. Available from: https:\/\/atm.amegroups.com\/article\/view\/60489\/html [cited 21 Jul 2022].","journal-title":"Ann Transl Med"},{"key":"1736_CR198","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","volume":"32","author":"N Bolli","year":"2018","unstructured":"Bolli N, Biancon G, Moarii M, Gimondi S, Li Y, de Philippis C, et al. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Leukemia. 2018;32:2604\u201316.","journal-title":"Leukemia."},{"issue":"11","key":"1736_CR199","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/s41375-018-0103-3","volume":"32","author":"PH Hoang","year":"2018","unstructured":"Hoang PH, Dobbins SE, Cornish AJ, Chubb D, Law PJ, Kaiser M, et al. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms. Leukemia. 2018;32(11):2459\u201370 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41375-018-0103-3 [cited 15 Jul 2022].","journal-title":"Leukemia"},{"key":"1736_CR200","doi-asserted-by":"crossref","unstructured":"Hoang PH, Cornish AJ, Sherborne AL, Chubb D, Kimber S, Jackson G, et al. An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics. Blood Cancer J. 2020;10(10):101. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/s41408-020-00367-2. [cited 15 Jul 2022].","DOI":"10.1038\/s41408-020-00367-2"},{"key":"1736_CR201","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1182\/blood.V128.22.116.116","volume":"128","author":"F Maura","year":"2016","unstructured":"Maura F, Bolli N, Minvielle S, Gloznik D, Szalat R, Fullam A, et al. Analysis of Mutational Signatures Suggest That Aid Has an Early and Driver Role in Multiple Myeloma. Blood. 2016;128:116 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/128\/22\/116\/96279\/Analysis-of-Mutational-Signatures-Suggest-That-Aid [cited 15 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR202","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","volume":"133","author":"S Ogawa","year":"2019","unstructured":"Ogawa S. Genetics of MDS. Blood. 2019;133:1049\u201359 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/133\/10\/1049\/272730\/Genetics-of-MDS [cited 22 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR203","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood-2016-04-708560","volume":"129","author":"T Kim","year":"2017","unstructured":"Kim T, Tyndel MS, Kim HJ, Ahn J-S, Choi SH, Park HJ, et al. Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy. Blood. 2017;129:38\u201347.","journal-title":"Blood."},{"key":"1736_CR204","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41375-021-01331-0","volume":"36","author":"A Behnert","year":"2022","unstructured":"Behnert A, Meyer J, Parsa JY, Hechmer A, Loh ML, Olshen A, et al. Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples. Leukemia. 2022;36:279\u201382 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34183765\/ [cited 21 Oct 2022].","journal-title":"Leukemia"},{"key":"1736_CR205","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/cancers14051335","volume":"14","author":"C Fi\u00f1ana","year":"2022","unstructured":"Fi\u00f1ana C, G\u00f3mez-Molina N, Alonso-Moreno S, Belver L. Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia. Cancers (Basel). 2022;14:1335 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35267643\/ [cited 21 Oct 2022].","journal-title":"Cancers (Basel)"},{"key":"1736_CR206","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/10428194.2020.1856837","volume":"62","author":"AB Patel","year":"2021","unstructured":"Patel AB, Deininger MW. Genetic complexity of chronic myelomonocytic leukemia. Leuk Lymphoma. 2021;62:1031\u201345 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33337259\/ [cited 2022 Oct 21].","journal-title":"Leuk Lymphoma"},{"key":"1736_CR207","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1182\/blood.2019000611","volume":"134","author":"H Zhang","year":"2019","unstructured":"Zhang H, Wilmot B, Bottomly D, Dao KHT, Stevens E, Eide CA, et al. Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. Blood. 2019;134:867\u201379 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31366621\/ [cited 21 Oct 2022].","journal-title":"Blood"},{"key":"1736_CR208","first-page":"501","volume":"39","author":"SQ Qu","year":"2018","unstructured":"Qu SQ, Qin TJ, Xu ZF, Zhang Y, Jia YJ, Ai XF, et al. Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia. Zhonghua Xue Ye Xue Za Zhi. 2018;39:501\u20136.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1736_CR209","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3324\/haematol.2013.092379","volume":"98","author":"JD Merker","year":"2013","unstructured":"Merker JD, Roskin KM, Ng D, Pan C, Fisk DG, King JJ, et al. Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes. Haematologica. 2013;98:1689\u201396 Available from: https:\/\/haematologica.org\/article\/view\/6830 [cited 22 Jul 2022].","journal-title":"Haematologica"},{"key":"1736_CR210","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1182\/blood-2021-154281","volume":"138","author":"B Sadler","year":"2021","unstructured":"Sadler B, Chorzalska AD, Bonal DM, Haller G, Oakes A, Petersen M, et al. Whole genome sequencing identifies a recurrent mutation in complement factor I (CFI) in primary Myelofibrosis (PMF). Blood. 2021;138:1472.","journal-title":"Blood."},{"key":"1736_CR211","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, et al. Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2. N Engl J Med. 2013;369:2391\u2013405 Massachusetts Medical Society. Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1312542 [cited 2022 Jul 22].","journal-title":"N Engl J Med"},{"key":"1736_CR212","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood-2015-07-661983","volume":"127","author":"X Cabagnols","year":"2016","unstructured":"Cabagnols X, Favale F, Pasquier F, Messaoudi K, Defour JP, Ianotto JC, et al. Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients. Blood. 2016;127:333\u201342 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/127\/3\/333\/34889\/Presence-of-atypical-thrombopoietin-receptor-MPL [cited 22 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR213","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","volume":"127","author":"JD Milosevic Feenstra","year":"2016","unstructured":"Milosevic Feenstra JD, Nivarthi H, Gisslinger H, Leroy E, Rumi E, Chachoua I, et al. Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood. 2016;127:325\u201332 American Society of Hematology. Available from: https:\/\/ashpublications.org\/blood\/article\/127\/3\/325\/34897\/Whole-exome-sequencing-identifies-novel-MPL-and [cited 22 Jul 2022].","journal-title":"Blood"},{"key":"1736_CR214","doi-asserted-by":"crossref","unstructured":"K\u00fcnstner A, Schwarting J, Witte HM, Bernard V, St\u00f6lting S, Kusch K, et al. Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm. Blood Cancer J. 2022;12(7):101. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/s41408-022-00699-1. [cited 25 Jul 2022].","DOI":"10.1038\/s41408-022-00699-1"},{"key":"1736_CR215","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1200\/PO.20.00215","volume":"4","author":"MD Kinnaman","year":"2020","unstructured":"Kinnaman MD, Hamill D, Yabe M, Powell J, Benhamida J, Hasselblatt M, et al. Aggressive hematopoietic malignancy characterized by Biallelic loss of SMARCB1. JCO Precis Oncol. 2020;4:1280\u20134. https:\/\/doi.org\/10.1200\/PO.20.00215.","journal-title":"JCO Precis Oncol."},{"key":"1736_CR216","doi-asserted-by":"publisher","first-page":"37636","DOI":"10.18632\/oncotarget.9400","volume":"7","author":"E Margolskee","year":"2016","unstructured":"Margolskee E, Jobanputra V, Jain P, Chen J, Ganapathi K, Nahum O, et al. Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders. Oncotarget. 2016;7:37636\u201348.","journal-title":"Oncotarget."},{"key":"1736_CR217","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3324\/haematol.2019.230375","volume":"105","author":"C Egan","year":"2020","unstructured":"Egan C, Nicolae A, Lack J, Chung HJ, Skarshaug S, Pham TA, et al. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica. 2020;105:951\u201360 Ferrata Storti Foundation. Available from: https:\/\/haematologica.org\/article\/view\/9331 [cited 25 Jul 2022].","journal-title":"Haematologica"},{"key":"1736_CR218","doi-asserted-by":"publisher","first-page":"e28704","DOI":"10.1002\/pbc.28704","volume":"67","author":"C Jansen","year":"2020","unstructured":"Jansen C, Dykstra J, Callaway D, Lynch D, Cunningham A, Frohm ML. Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020;67:e28704 John Wiley & Sons, Ltd. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.28704 [cited 25 Jul 2022].","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR219","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41375-021-01225-1","volume":"35","author":"L Yao","year":"2021","unstructured":"Yao L, Yin H, Hong M, Wang Y, Yu T, Teng Y, et al. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications. Leukemia. 2021;35:1243\u201357 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33767371\/ [cited 4 Aug 2022].","journal-title":"Leukemia"},{"key":"1736_CR220","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/leu.2016.181","volume":"31","author":"LM Saleh","year":"2017","unstructured":"Saleh LM, Wang W, Herman SEM, Saba NS, Anastas V, Barber E, et al. Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia. Leukemia. 2017;31:340\u20139.","journal-title":"Leukemia."},{"key":"1736_CR221","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","volume":"23","author":"R van Doorn","year":"2005","unstructured":"van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA, et al. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol. 2005;23:3886\u201396 Proc Am Soc Clin Oncol.","journal-title":"J Clin Oncol"},{"key":"1736_CR222","doi-asserted-by":"crossref","unstructured":"Deambrogi C, de Paoli L, Fangazio M, Cresta S, Rasi S, Spina V, et al. Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia. Am J Hematol. 2010;85:541\u20134. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20575024\/. [cited 31 Oct 2022].","DOI":"10.1002\/ajh.21742"},{"key":"1736_CR223","doi-asserted-by":"crossref","unstructured":"Tosic N, Ugrin M, Marjanovic I, Kostic T, Vukovic V, Tomic K, et al. Expression of BCL11A in chronic lymphocytic leukaemia. Int J Lab Hematol. 2023;45:64\u201371. Wiley.\u00a0Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/ijlh.13969. [cited 31 Oct 2022].","DOI":"10.1111\/ijlh.13969"},{"key":"1736_CR224","doi-asserted-by":"publisher","first-page":"755188","DOI":"10.3389\/fonc.2021.755188","volume":"11","author":"LL Wang","year":"2021","unstructured":"Wang LL, Yan D, Tang X, Zhang M, Liu S, Wang Y, et al. High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL. Front Oncol. 2021;11:755188 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34938655\/ [cited 31 Oct 2022].","journal-title":"Front Oncol"},{"key":"1736_CR225","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.leukres.2015.12.001","volume":"41","author":"H Tao","year":"2016","unstructured":"Tao H, Ma X, Su G, Yin J, Xie X, Hu C, et al. BCL11A expression in acute myeloid leukemia. Leuk Res. 2016;41:71\u20135 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26707798\/ [cited 31 Oct 2022].","journal-title":"Leuk Res"},{"key":"1736_CR226","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.leukres.2016.05.018","volume":"47","author":"J Yin","year":"2016","unstructured":"Yin J, Zhang F, Tao H, Ma X, Su G, Xie X, et al. BCL11A expression in acute phase chronic myeloid leukemia. Leuk Res. 2016;47:88\u201392 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27285855\/ [cited 31 Oct 2022].","journal-title":"Leuk Res"},{"key":"1736_CR227","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12094-017-1633-2","volume":"19","author":"M Cuadros","year":"2017","unstructured":"Cuadros M, S\u00e1nchez-Mart\u00edn V, Herrera A, Bali\u00f1as C, Mart\u00edn-Padr\u00f3n J, Boyero L, et al. BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines. Clin Transl Oncol. 2017;19:1010\u20137 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28251496\/ [cited 9 Aug 2022].","journal-title":"Clin Transl Oncol"},{"key":"1736_CR228","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/15384047.2018.1504721","volume":"20","author":"Y Chang","year":"2019","unstructured":"Chang Y, Cui M, Fu X, Zhang L, Li X, Li L, et al. MiRNA-155 regulates lymphangiogenesis in natural killer\/T-cell lymphoma by targeting BRG1. Cancer Biol Ther. 2019;20:31\u201341.","journal-title":"Cancer Biol Ther."},{"key":"1736_CR229","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1080\/10428194.2017.1422861","volume":"59","author":"Y Li","year":"2018","unstructured":"Li Y, Wang J, Yu M, Wang Y, Zhang H, Yin J, et al. SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in S\u00e9zary syndrome. Leuk Lymphoma. 2018;59:2405\u201313 Taylor & Francis. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/10428194.2017.1422861 [cited 16 Jan 2023].","journal-title":"Leuk Lymphoma"},{"key":"1736_CR230","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20:21\u201337.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1736_CR231","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/hmg\/ddu554","volume":"24","author":"IF Coira","year":"2015","unstructured":"Coira IF, Rufino-Palomares EE, Romero OA, Peinado P, Metheetrairut C, Boyero-Corral L, et al. Expression inactivation of SMARCA4 by microRNAs in lung tumors. Hum Mol Genet. 2015;24:1400\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25355421\/ [cited 11 Nov 2022].","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1736_CR232","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41591-018-0243-z","volume":"25","author":"R Agarwal","year":"2018","unstructured":"Agarwal R, Chan YC, Tam CS, Hunter T, Vassiliadis D, Teh CE, et al. Dynamic molecular monitoring reveals that SWI\u2013SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma. Nat Med. 2018;25(1):119\u201329 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41591-018-0243-z [cited 15 Nov 2022].","journal-title":"Nat Med"},{"key":"1736_CR233","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1158\/0008-5472.CAN-16-0716","volume":"76","author":"R Dubey","year":"2016","unstructured":"Dubey R, Lebensohn AM, Bahrami-Nejad Z, Marceau C, Champion M, Gevaert O, et al. Chromatin-Remodeling Complex SWI\/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1. Cancer Res. 2016;76:5810\u201321 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27503929\/ [cited 15 Nov 2022].","journal-title":"Cancer Res"},{"key":"1736_CR234","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"RL Juliano","year":"1976","unstructured":"Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455:152\u201362 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/990323\/ [cited 15 Nov 2022].","journal-title":"Biochim Biophys Acta"},{"key":"1736_CR235","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/jnci\/djn416","volume":"100","author":"N Pottier","year":"2008","unstructured":"Pottier N, Yang W, Assem M, Panetta JC, Pei D, Paugh SW, et al. The SWI\/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst. 2008;100:1792\u2013803. https:\/\/doi.org\/10.1093\/jnci\/djn416.","journal-title":"J Natl Cancer Inst"},{"key":"1736_CR236","first-page":"166","volume":"3","author":"H-J Kim","year":"2011","unstructured":"Kim H-J, Bae S-C. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3:166\u201379 Available from: www.ajtr.org.","journal-title":"Am J Transl Res"},{"key":"1736_CR237","doi-asserted-by":"publisher","first-page":"805195","DOI":"10.3389\/fcell.2021.805195","volume":"9","author":"I Serganova","year":"2022","unstructured":"Serganova I, Chakraborty S, Yamshon S, Isshiki Y, Bucktrout R, Melnick A, et al. Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies. Front Cell Dev Biol. 2022;9:805195 Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.805195.","journal-title":"Front Cell Dev Biol"},{"key":"1736_CR238","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.3390\/cancers13174249","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang X, Wang D, Ding N, Mi L, Yu H, Wu M, et al. The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma. Cancers (Basel). 2021;13:4249 Available from: https:\/\/www.mdpi.com\/2072-6694\/13\/17\/4249.","journal-title":"Cancers (Basel)"},{"key":"1736_CR239","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/s41467-021-24618-3","volume":"12","author":"OA Romero","year":"2021","unstructured":"Romero OA, Vilarrubi A, Alburquerque-Bejar JJ, Gomez A, Andrades A, Trastulli D, et al. SMARCA4 deficient tumours are vulnerable to KDM6A\/UTX and KDM6B\/JMJD3 blockade. Nat Commun. 2021;12:4319. https:\/\/doi.org\/10.1038\/s41467-021-24618-3.","journal-title":"Nat Commun"},{"key":"1736_CR240","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nm.3480","volume":"20","author":"KC Helming","year":"2014","unstructured":"Helming KC, Wang X, Wilson BG, Vazquez F, Haswell JR, Manchester HE, et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat Med. 2014;20:251\u20134 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24562383\/ [cited 14 Nov 2022].","journal-title":"Nat Med"},{"key":"1736_CR241","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1158\/0008-5472.CAN-09-0733","volume":"69","author":"W Xi","year":"2009","unstructured":"Xi W, Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PTL, et al. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI\/SNF chromatin remodeling complex. Cancer Res. 2009;69:8094\u2013101 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19789351\/ [cited 14 Nov 2022].","journal-title":"Cancer Res"},{"key":"1736_CR242","doi-asserted-by":"crossref","unstructured":"Schiaffino-Ortega S, Balinas C, Cuadros M, Medina PP. SWI\/SNF proteins as targets in cancer therapy. J Hematol Oncol. 2014;7:81. BioMed Central Ltd.\u00a0Available from: https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-014-0081-5. [cited 11 Nov 2022].","DOI":"10.1186\/s13045-014-0081-5"},{"key":"1736_CR243","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1073\/pnas.1316793111","volume":"111","author":"GR Hoffman","year":"2014","unstructured":"Hoffman GR, Rahal R, Buxton F, Xiang K, McAllister G, Frias E, et al. Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers. Proc Natl Acad Sci U S A. 2014;111:3128\u201333 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24520176\/ [cited 6 Sep 2022].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1736_CR244","doi-asserted-by":"crossref","unstructured":"Jagani Z, Chenail G, Xiang K, Bushold G, Bhang H-EC, Li A, et al. In-Depth Characterization and Validation in BRG1-Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI\/SNF Chromatin Remodeling. bioRxiv. 2019:812628. Cold Spring Harbor Laboratory.\u00a0Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/812628v1. [cited 5 Sep 2022].","DOI":"10.1101\/812628"},{"key":"1736_CR245","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1021\/acs.jmedchem.8b01318","volume":"61","author":"JPN Papillon","year":"2018","unstructured":"Papillon JPN, Nakajima K, Adair CD, Hempel J, Jouk AO, Karki RG, et al. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)\/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)\/SMARCA4-Mutant Cancers. J Med Chem. 2018;61:10155\u201372 American Chemical Society. Available from: https:\/\/pubs.acs.org\/doi\/full\/10.1021\/acs.jmedchem.8b01318 [cited 5 Sep 2022].","journal-title":"J Med Chem"},{"issue":"7","key":"1736_CR246","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","volume":"15","author":"W Farnaby","year":"2019","unstructured":"Farnaby W, Koegl M, Roy MJ, Whitworth C, Diers E, Trainor N, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019;15(7):672\u201380 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41589-019-0294-6 [cited 11 Nov 2022].","journal-title":"Nat Chem Biol"},{"key":"1736_CR247","doi-asserted-by":"crossref","unstructured":"Kofink C, Trainor N, Mair B, W\u00f6hrle S, Wurm M, Mischerikow N, et al. A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo. Nat Commun. 2022;13(1):5969. Nature Publishing Group.\u00a0Available from: https:\/\/www.nature.com\/articles\/s41467-022-33430-6. [cited 2 Nov 2022].","DOI":"10.1038\/s41467-022-33430-6"},{"issue":"3","key":"1736_CR248","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022;21(3):181\u2013200 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/s41573-021-00371-6 [cited 26 Oct 2022].","journal-title":"Nat Rev Drug Discov"},{"key":"1736_CR249","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","volume":"20","author":"BC Michel","year":"2018","unstructured":"Michel BC, D\u2019Avino AR, Cassel SH, Mashtalir N, McKenzie ZM, McBride MJ, et al. A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nat Cell Biol. 2018;20:1410\u201320 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30397315\/ [cited 5 Sep 2022].","journal-title":"Nat Cell Biol"},{"key":"1736_CR250","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.jmedchem.8b01413","volume":"62","author":"V Zoppi","year":"2019","unstructured":"Zoppi V, Hughes SJ, Maniaci C, Testa A, Gmaschitz T, Wieshofer C, et al. Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7. J Med Chem. 2019;62:699\u2013726 American Chemical Society. Available from: https:\/\/pubs.acs.org\/doi\/full\/10.1021\/acs.jmedchem.8b01413 [cited 8 Sep 2022].","journal-title":"J Med Chem"},{"key":"1736_CR251","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41467-019-09891-7","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Wang S, Troisi EC, Howard TP, Haswell JR, Wolf BK, et al. BRD9 defines a SWI\/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors. Nat Commun. 2019;10:1881 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31015438\/ [cited 5 Sep 2022].","journal-title":"Nat Commun"},{"key":"1736_CR252","doi-asserted-by":"crossref","unstructured":"Tamkun JW, Deuring R, Scott MP, Kissinger M, Pattatucci AM, Kaufman TC, et al. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2\/SWI2. Cell. 1992;68:561\u201372. Elsevier.\u00a0Available from: http:\/\/www.cell.com\/article\/009286749290191E\/fulltext. [cited 18 Jul 2022].","DOI":"10.1016\/0092-8674(92)90191-E"},{"issue":"2","key":"1736_CR253","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ng.3734","volume":"49","author":"C Kadoch","year":"2016","unstructured":"Kadoch C, Williams RT, Calarco JP, Miller EL, Weber CM, Braun SMG, et al. Dynamics of BAF\u2013Polycomb complex opposition on heterochromatin in normal and oncogenic states. Nat Genet. 2016;49(2):213\u201322 Nature Publishing Group. Available from: https:\/\/www.nature.com\/articles\/ng.3734 [cited 18 Jul 2022].","journal-title":"Nat Genet"},{"key":"1736_CR254","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim KH, Roberts CWM. Targeting EZH2 in cancer. Nat Med. 2016;22:128\u201334 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26845405\/ [cited 7 Sep 2022].","journal-title":"Nat Med"},{"key":"1736_CR255","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nchembio.1331","volume":"9","author":"W Kim","year":"2013","unstructured":"Kim W, Bird GH, Neff T, Guo G, Kerenyi MA, Walensky LD, et al. Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer. Nat Chem Biol. 2013;9:643\u201350 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23974116\/ [cited 7 Sep 2022].","journal-title":"Nat Chem Biol"},{"key":"1736_CR256","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1080\/10428194.2018.1430795","volume":"59","author":"N Gulati","year":"2018","unstructured":"Gulati N, B\u00e9guelin W, Giulino-Roth L. Enhancer of zeste homolog 2 (EZH2) inhibitors. Leuk Lymphoma. 2018;59:1574\u201385 Taylor and Francis Ltd.","journal-title":"Leuk Lymphoma"},{"key":"1736_CR257","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/bloodadvances.2020002773","volume":"5","author":"RD Morin","year":"2021","unstructured":"Morin RD, Arthur SE, Assouline S. Treating lymphoma is now a bit EZ-er. Blood Adv. 2021;5:2256\u201363. https:\/\/doi.org\/10.1182\/bloodadvances.2020002773.","journal-title":"Blood Adv"},{"key":"1736_CR258","doi-asserted-by":"publisher","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","volume":"13","author":"R Straining","year":"2022","unstructured":"Straining R, Eighmy W. Tazemetostat: EZH2 Inhibitor. J Adv Pract Oncol. 2022;13:158\u201363 Harborside Press, LLC.","journal-title":"J Adv Pract Oncol"},{"key":"1736_CR259","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/ng.3958","volume":"49","author":"RT Nakayama","year":"2017","unstructured":"Nakayama RT, Pulice JL, Valencia AM, McBride MJ, McKenzie ZM, Gillespie MA, et al. SMARCB1 is required for widespread BAF complex\u2013mediated activation of enhancers and bivalent promoters. Nat Genet. 2017;49:1613\u201323.","journal-title":"Nat Genet"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-023-01736-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T04:07:21Z","timestamp":1676952441000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-023-01736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":259,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1186\/s12943-023-01736-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}